a public good project by the
Synthesis
Company
of California

© 2026

Philip Berry | doi.page

0 works0 citations0 h-index

Philip Berry

King's College London(GB)Guy's and St Thomas' NHS Foundation Trust(GB)St. Thomas Hospital(CA)

Publications by Year

Research Areas

Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Glioma Diagnosis and Treatment, Nanoplatforms for cancer theranostics, Palliative Care and End-of-Life Issues

Most-Cited Works

→ The importance of immune dysfunction in determining outcome in acute liver failure(2008)359 cited
→ Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study(2010)218 cited
→ Reduced monocyte HLA-DR expression: A novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure(2006)166 cited
→ Kingʼs Score: an accurate marker of cirrhosis in chronic hepatitis C(2009)148 cited
→ Immunolocalization of catecholamine enzymes, serotonin, dopamine and L-dopa in the brain o/.f dicentrarchus labrax (teleostei)(1993)89 cited
→ Hepatic Dysfunction in Sickle Cell Disease: A New System of Classification Based on Global Assessment(2007)87 cited

→ The relationship between body composition and structural changes at the knee(2010)77 cited

→ Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis(2010)76 cited

→ Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis(2010)74 cited

→ Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers(2009)72 cited